share_log

翰森製藥：董事會召開日期

HANSOH PHARMA: DATE OF BOARD MEETING

香港交易所 ·  Mar 14 04:49
Summary by Moomoo AI
翰森製藥集團有限公司宣布，將於2024年3月26日（星期二）召開董事會會議。會議的主要目的是考慮及通過該公司及其附屬公司截至2023年12月31日止年度的全年業績，並討論建議的末期股息（如有）。此外，會議還將處理其他事項。董事會成員包括主席兼執行董事鍾慧娟女士、執行董事呂愛鋒先生及孫遠女士；以及獨立非執行董事林國強先生、陳尚偉先生及楊東濤女士。
翰森製藥集團有限公司宣布，將於2024年3月26日（星期二）召開董事會會議。會議的主要目的是考慮及通過該公司及其附屬公司截至2023年12月31日止年度的全年業績，並討論建議的末期股息（如有）。此外，會議還將處理其他事項。董事會成員包括主席兼執行董事鍾慧娟女士、執行董事呂愛鋒先生及孫遠女士；以及獨立非執行董事林國強先生、陳尚偉先生及楊東濤女士。
HANSEN PHARMACEUTICAL GROUP LIMITED ANNOUNCES THAT A BOARD MEETING WILL BE HELD ON TUESDAY, MARCH 26, 2024. The primary purpose of the meeting is to consider and approve the annual results of the Company and its subsidiaries for the year ended 31 December 2023 and to discuss the proposed final dividend (if any). In addition, the meeting will deal with other matters. The members of the Board of Directors include Chairman and Executive Director Ms. Chung Wai Chuan, Executive Director Mr. Lu Aifeng and Ms. Sun Yuen; and Independent Non-Executive Directors Mr. Lin Guoqiang, Mr. Chan Shang Wei and Ms. Yang Tong Tao.
HANSEN PHARMACEUTICAL GROUP LIMITED ANNOUNCES THAT A BOARD MEETING WILL BE HELD ON TUESDAY, MARCH 26, 2024. The primary purpose of the meeting is to consider and approve the annual results of the Company and its subsidiaries for the year ended 31 December 2023 and to discuss the proposed final dividend (if any). In addition, the meeting will deal with other matters. The members of the Board of Directors include Chairman and Executive Director Ms. Chung Wai Chuan, Executive Director Mr. Lu Aifeng and Ms. Sun Yuen; and Independent Non-Executive Directors Mr. Lin Guoqiang, Mr. Chan Shang Wei and Ms. Yang Tong Tao.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more